Want Decades of Passive Income? 3 Stocks to Buy Now and Hold Forever.

Core Insights - The healthcare industry is highlighted as a strong sector for passive income, with companies like Novo Nordisk, Eli Lilly, and AbbVie positioned as top dividend growth stocks for the future [1] Group 1: Novo Nordisk - Novo Nordisk has made significant advancements in weight management with its GLP-1 drugs, Ozempic and Wegovy, which treat Type 2 diabetes and chronic weight management [2] - The company has a solid dividend yield of 1.5% and has experienced an average annual dividend growth of 6.5% over the past five years, with potential for larger increases due to a favorable growth outlook [3] Group 2: Eli Lilly - Eli Lilly is a diversified pharmaceutical company with a strong product lineup across various therapeutic areas, including a competing product to Ozempic called Mounjaro [4] - The company has $36 billion in annual revenue and is expected to see earnings compound at a rate of 36% annually over the next three to five years, which could lead to significant dividend growth [5] Group 3: AbbVie - AbbVie has transitioned successfully from its top-selling drug Humira to new products like Skyrizi and Rinvoq, generating a combined sales run rate of $12 billion this year [6] - The company offers a robust dividend yield of 3.8% and is projected to have an annualized earnings growth of 7%, contributing to total returns of 10% to 11% for investors [7]